| 346 |
376: Increased, Induced Mutations in Critical Genes |
378: Tumorigenesis, Hepatocellular carcinoma |
Nov 29, 2016 |
Nov 30, 2016 |
1 AOP
|
| 351 |
376: Increased, Induced Mutations in Critical Genes |
384: Increased, Clonal Expansion / Cell Proliferatin to form Pre-Neoplastic Altered Hepatic Foci |
Nov 29, 2016 |
Nov 29, 2016 |
None
|
| 549 |
376: Increased, Induced Mutations in Critical Genes |
491: Clonal Expansion/Cell Proliferation, to form Altered Hepatic Foci (AHF) |
Nov 29, 2016 |
Nov 29, 2016 |
1 AOP
|
| 891 |
376: Increased, Induced Mutations in Critical Genes |
872: Increase, Site of Contact Nasal Tumors |
Nov 29, 2016 |
Dec 3, 2016 |
None
|
| 762 |
726: Increased, Induction of pyruvate dehydrogenase (PDH) |
769: Increase, Oxidative metabolism |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 1063 |
1020: Increased, induction of UDPGT's in liver |
1021: Increased, T4/T3 catabolism |
Nov 29, 2016 |
Dec 3, 2016 |
None
|
| 1127 |
1087: Increased, inflammation |
1032: Increased, secretion of local growth factors |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 1048 |
1012: Increased, Inhibitory postsynaptic potential |
1013: Inhibition, Motor neuron activity |
Nov 29, 2016 |
Dec 3, 2016 |
None
|
| 1054 |
1012: Increased, Inhibitory postsynaptic potential |
1014: Induction, Somatic muscle paralysis |
Nov 29, 2016 |
Dec 3, 2016 |
2 AOPs
|
| 1058 |
1012: Increased, Inhibitory postsynaptic potential |
1019: Induction, pharyngeal muscle paralysis |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 547 |
493: Increased, Insufficient repair or mis-repair of pro-mutagenic DNA adducts |
376: Increased, Induced Mutations in Critical Genes |
Nov 29, 2016 |
Nov 29, 2016 |
1 AOP
|
| 362 |
389: Increased, Intracellular Calcium overload |
177: Increase, Mitochondrial dysfunction |
Nov 29, 2016 |
Nov 29, 2016 |
2 AOPs
|
| 892 |
389: Increased, Intracellular Calcium overload |
618: Decreased, Neuronal network function in adult brain |
Nov 29, 2016 |
Dec 3, 2016 |
None
|
| 1860 |
389: Increased, Intracellular Calcium overload |
613: Occurrence, Epileptic seizure |
Feb 13, 2019 |
Feb 13, 2019 |
None
|
| 1862 |
389: Increased, Intracellular Calcium overload |
55: Cell injury/death |
Feb 19, 2019 |
Sep 3, 2023 |
1 AOP
|
| 2140 |
389: Increased, Intracellular Calcium overload |
1788: Status epilepticus |
May 21, 2020 |
May 21, 2020 |
None
|
| 2704 |
389: Increased, Intracellular Calcium overload |
2038: Activation, calpain |
Jul 25, 2022 |
Jul 25, 2022 |
1 AOP
|
| 2709 |
389: Increased, Intracellular Calcium overload |
1477: OXPHOS, decreased |
Jul 25, 2022 |
Jul 25, 2022 |
None
|
| 2710 |
389: Increased, Intracellular Calcium overload |
2017: Endoplasmic reticulum stress |
Jul 25, 2022 |
Jul 25, 2022 |
1 AOP
|
| 3042 |
389: Increased, Intracellular Calcium overload |
1816: Mitochondrial dysfunction EMPTY |
Sep 14, 2023 |
Sep 14, 2023 |
None
|
| 3091 |
389: Increased, Intracellular Calcium overload |
2078: Loss of drebrin |
Oct 18, 2023 |
Apr 4, 2025 |
1 AOP
|
| 3248 |
389: Increased, Intracellular Calcium overload |
1392: Increase, Oxidative Stress |
Jun 19, 2024 |
Jun 19, 2024 |
1 AOP
|
| 3256 |
389: Increased, Intracellular Calcium overload |
2151: Disruption, neurotransmitter release |
Jun 19, 2024 |
Jun 19, 2024 |
1 AOP
|
| 3426 |
389: Increased, Intracellular Calcium overload |
1532: Decrease, Cardiac contractility |
Nov 21, 2024 |
Nov 21, 2024 |
2 AOPs
|
| 1465 |
1322: Increased, intracellular chloride (Cl-) |
1356: Inactive, membrane depolarization |
Apr 14, 2017 |
Apr 14, 2017 |
1 AOP
|